Eagle Genomics and Earlham Institute reveal bioinformatics power play
Cambridge’s Eagle Genomics and the Earlham Institute in Norwich have joined forces to deliver new microbiome multi-omics datasets and tools.
The alliance will enable access to novel datasets and innovation workflows through Eagle Genomics’ AI-augmented knowledge discovery platform. Applied across both academia and industry, the partnership will facilitate access to unique resources while accelerating data-driven collaboration.
As Eagle Genomics’ foundational knowledge partner, the Earlham Institute brings a wealth of expertise in genomics and bioinformatics, as well as developing and testing laboratory methods and computational biology pipelines to study microbial communities.
The Institute has already developed a number of successful tools and datasets for bioinformaticians – such as Signalink, SalmoNet, STRONG and LotuS2.
Eagle Genomics’ platform, e[datascientist]™, applies network science to multi-dimensional life sciences data – including environmental and clinical metagenomes for multi-omics analysis.
It accelerates research and development into the understanding of human-microbiome interactions to support innovation workflows, including the generation of product claims.
Anthony Finbow, CEO of Eagle Genomics, said: “Eagle Genomics’ industry-leading open platform is helping drive the digital reinvention of life sciences R & D across numerous industries, from AgBio and food through to healthcare, personal care and beauty.
“Our partnership with the Earlham Institute is a clear demonstration of our commitment to enable a radical, global shift in microbiome science-led innovation.
“By harnessing nature – including its complex networks and associated multi-dimensional data – we can help tackle the world’s Grand Challenges while unlocking significant economic potential.”
Eagle Genomics’ partnership with the Earlham Institute will range from collaborative R & D to consultancy work and licensing, as well as deploying e[datascientist]’s hosting and networking capabilities.
It will also provide strategic insight as part of a steering group on new pipelines, and for example, could include research into:-
- Classification and genome reconstruction in complex environments
- Biological signalling network resources for human and model organisms
- Global patterns of antimicrobial resistance found in microbes
- Investigating the persistence and evolution of human associated microbes
Dr Andrew Tingey, senior director, Global Licensing and IP Strategy at Eagle Genomics, said: “At Eagle, we’re using network science and world-leading AI tools to unlock the potential for innovation from complex multi-dimensional microbiome data.
“Our new partnership with the Earlham Institute will help support the global microbiome R & D community while shaping the future of metagenomics, linking world-leading bioinformatics pipelines, tools, and datasets.”
Eagle Genomics is currently in discussions with a range of other organisations to ensure that its platform continues to evolve as the burgeoning global life sciences knowledge discovery hub.